Epithelial cells lining salivary gland ducts are early target cells of severe acute respiratory syndrome coronavirus infection in the upper respiratory tracts of rhesus macaques

Journal of Virology

Volumn 85, Issue 8, 2011, Pages 4025-4030

  Liu, Li ^a   Wei, Qiang ^b   Alvarez, Xavier ^c   Wang, Haibo ^a   Du, Yanhua ^a   Zhu, Hua ^b   Jiang, Hong ^b   Zhou, Jingying ^a   Lam, Pokman ^a   Zhang, Linqi ^d   Lackner, Andrew ^c   Qin, Chuan ^b   Chen, Zhiwei ^a,e  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b INSTITUTE OF LABORATORY ANIMAL SCIENCE   (China)

^c TULANE NATIONAL PRIMATE RESEARCH CENTER   (United States)

^d TSINGHUA UNIVERSITY   (China)

^e UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CHINESE; CONTROLLED STUDY; EPITHELIUM CELL; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; SALIVARY GLAND DUCT; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; TARGET CELL; UPPER RESPIRATORY TRACT;

ANIMALS; EPITHELIAL CELLS; IMMUNOHISTOCHEMISTRY; MACACA MULATTA; MICROSCOPY; PEPTIDYL-DIPEPTIDASE A; RECEPTORS, VIRUS; SALIVARY DUCTS; SARS VIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; VIRAL LOAD;

MACACA; MACACA MULATTA; SARS CORONAVIRUS;

EID: 79952831478     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02292-10     Document Type: Article

References (46)

1. Bukreyev, A., et al. 2004. Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS. Lancet 363:2122-2127. (Pubitemid 38844152)
2. Chen, Y., et al. 2007. A novel subset of putative stem/progenitor CD34+Oct-4+ cells is the major target for SARS coronavirus in human lung. J. Exp. Med. 204:2529-2536.
3. Chen, Y., et al. 2008. Rhesus angiotensin converting enzyme 2 supports entry of severe acute respiratory syndrome coronavirus in Chinese macaques. Virology 381:89-97.
4. Chen, Z., A. Gettie, D. D. Ho, and P. A. Marx. 1998. Primary SIVsm isolates use the CCR5 coreceptor from sooty mangabeys naturally infected in west Africa: a comparison of coreceptor usage of primary SIVsm, HIV-2, and SIVmac. Virology 246:113-124.
5. Chen, Z., et al. 2005. Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region. J. Virol. 79:2678-2688. (Pubitemid 40270546)
6. Chen, Z., P. Zhou, D. D. Ho, N. R. Landau, and P. A. Marx. 1997. Genetically divergent strains of simian immunodeficiency virus use CCR5 as a coreceptor for entry. J. Virol. 71:2705-2714.
7. Chow, K. C., C. H. Hsiao, T. Y. Lin, C. L. Chen, and S. H. Chiou. 2004. Detection of severe acute respiratory syndrome-associated coronavirus in pneumocytes of the lung. Am. J. Clin. Pathol. 121:574-580.
8. Chu, Y. K., et al. 2008. The SARS-CoV ferret model in an infection-challenge study. Virology 374:151-163.
9. Darnell, M. E., et al. 2007. Severe acute respiratory syndrome coronavirus infection in vaccinated ferrets. J. Infect. Dis. 196:1329-1338.
10. Ding, Y., et al. 2004. Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways. J. Pathol. 203:622-630. (Pubitemid 38714098)
11. Drosten, C., et al. 2003. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N. Engl. J. Med. 348:1967-1976.
12. Greenough, T. C., et al. 2005. Pneumonitis and multi-organ system disease in common marmosets (Callithrix jacchus) infected with the severe acute respiratory syndrome-associated coronavirus. Am. J. Pathol. 167:455-463.
13. Gu, J., et al. 2005. Multiple organ infection and the pathogenesis of SARS. J. Exp. Med. 202:415-424.
14. Haagmans, B. L., et al. 2004. Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques. Nat. Med. 10:290-293.
15. Hamming, I., et al. 2004. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J. Pathol. 203:631-637.
16. Harmer, D., M. Gilbert, R. Borman, and K. L. Clark. 2002. Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme. FEBS Lett. 532:107-110.
17. Holt, C. E., N. Garlick, and E. Cornel. 1990. Lipofection of cDNAs in the embryonic vertebrate central nervous system. Neuron 4:203-214. (Pubitemid 20164175)
18. Huang, Y., Z. Y. Yang, W. P. Kong, and G. J. Nabel. 2004. Generation of synthetic severe acute respiratory syndrome coronavirus pseudoparticles: implications for assembly and vaccine production. J. Virol. 78:12557-12565.
19. Ishii, K., et al. 2009. Neutralizing antibody against severe acute respiratory syndrome (SARS)-coronavirus spike is highly effective for the protection of mice in the murine SARS model. Microbiol. Immunol. 53:75-82.
20. Ksiazek, T. G., et al. 2003. A novel coronavirus associated with severe acute respiratory syndrome. N. Engl. J. Med. 348:1953-1966.
21. Kuba, K., et al. 2005. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat. Med. 11:875-879.
22. Lawler, J. V., et al. 2006. Cynomolgus macaque as an animal model for severe acute respiratory syndrome. PLoS Med. 3:e149.
23. Li, W., et al. 2003. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426:450-454. (Pubitemid 37490132)
24. Li, W., et al. 2005. Bats are natural reservoirs of SARS-like coronaviruses. Science 310:676-679. (Pubitemid 41528160)
25. Liu, L., et al. 2007. Natural mutations in the receptor binding domain of spike glycoprotein determine the reactivity of cross-neutralization between palm civet coronavirus and severe acute respiratory syndrome coronavirus. J. Virol. 81:4694-4700. (Pubitemid 46668666)
26. Martina, B. E., et al. 2003. Virology: SARS virus infection of cats and ferrets. Nature 425:915. (Pubitemid 37376916)
27. McAuliffe, J., et al. 2004. Replication of SARS coronavirus administered into the respiratory tract of African Green, rhesus and cynomolgus monkeys. Virology 330:8-15. (Pubitemid 39446562)
28. Nakajima, N., et al. 2003. SARS coronavirus-infected cells in lung detected by new in situ hybridization technique. Jpn. J. Infect. Dis. 56:139-141.
29. Nicholls, J. M., et al. 2006. Time course and cellular localization of SARS-CoV nucleoprotein and RNA in lungs from fatal cases of SARS. PLoS Med. 3:e27.
30. Peiris, J. S., et al. 2003. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 361:1319-1325. (Pubitemid 36514862)
31. Qin, C., et al. 2005. An animal model of SARS produced by infection of Macaca mulatta with SARS coronavirus. J. Pathol. 206:251-259. (Pubitemid 40903189)
32. Roberts, A., et al. 2005. Aged BALB/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans. J. Virol. 79:5833-5838. (Pubitemid 40548251)
33. Roberts, A., et al. 2005. Severe acute respiratory syndrome coronavirus infection of golden Syrian hamsters. J. Virol. 79:503-511. (Pubitemid 39648403)
34. Rockx, B., et al. 2009. Early upregulation of acute respiratory distress syndrome-associated cytokines promotes lethal disease in an aged-mouse model of severe acute respiratory syndrome coronavirus infection. J. Virol. 83:7062-7074.
35. Rowe, T., et al. 2004. Macaque model for severe acute respiratory syndrome. J. Virol. 78:11401-11404. (Pubitemid 39299682)
36. Sheahan, T., et al. 2008. MyD88 is required for protection from lethal infection with a mouse-adapted SARS-CoV. PLoS Pathog. 4:e1000240.
37. Smits, S. L., et al. 2010. Exacerbated innate host response to SARS-CoV in aged non-human primates. PLoS Pathog. 6:e1000756.
38. Stremlau, M., et al. 2004. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 427:848-853. (Pubitemid 38297747)
39. To, K. F., et al. 2004. Tissue and cellular tropism of the coronavirus associated with severe acute respiratory syndrome: an in-situ hybridization study of fatal cases. J. Pathol. 202:157-163. (Pubitemid 38208652)
40. Wang, H., S. Rao, and C. Jiang. 2007. Molecular pathogenesis of severe acute respiratory syndrome. Microbes Infect. 9:119-126. (Pubitemid 46149412)
41. Wang, W. K., et al. 2004. Detection of SARS-associated coronavirus in throat wash and saliva in early diagnosis. Emerg. Infect. Dis. 10:1213-1219.
42. Williams, K. C., et al. 2001. Perivascular macrophages are the primary cell type productively infected by simian immunodeficiency virus in the brains of macaques: implications for the neuropathogenesis of AIDS. J. Exp. Med. 193:905-915.
43. Yang, Z. Y., et al. 2004. A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice. Nature 428:561-564.
44. Ye, J., et al. 2007. Molecular pathology in the lungs of severe acute respiratory syndrome patients. Am. J. Pathol. 170:538-545.
45. Yi, C. E., L. Ba, L. Zhang, D. D. Ho, and Z. Chen. 2005. Single amino acid substitutions in the severe acute respiratory syndrome coronavirus spike glycoprotein determine viral entry and immunogenicity of a major neutralizing domain. J. Virol. 79:11638-11646. (Pubitemid 41279282)
46. Zhang, L., et al. 2006. Antibody responses against SARS coronavirus are correlated with disease outcome of infected individuals. J. Med. Virol. 78:1-8.